Normal immunoglobulin human 4g/20ml solution for injection vials
NHS hospitals in England used £15,146,052 of indicative cost of Normal immunoglobulin human 4g/20ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 114.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Normal immunoglobulin human 4g/20ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Normal immunoglobulin human 4g/20ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Cambridge Univ Hosp Nhs Foundation Trust | £3,183,108 |
| Salford Royal Nhs Foundation Trust | £1,125,252 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,059,288 |
| University Hospitals Plymouth Nhs Trust | £1,039,140 |
| Barts Health Nhs Trust | £913,560 |
| Royal Papworth Hospital Nhs Ft | £740,232 |
| Royal Free London Nhs Foundation Trust | £702,144 |
| University Hpls Of Leicester Nhs Trust | £561,384 |
| University Hospital Southampton Nhs Ft | £521,088 |
| Frimley Health Nhs Foundation Trust | £494,868 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.